2) Blocking the TLR5/MyD88/NF-κB pathway activation decreased the cytokines that signal through MyD88, such as IL-1β and IL-6, alleviated TNBS induced colitis, and maintained intestinal homeostasis. The gene discussed is IL1B; the disease is colitis.